ArticleBioengineered2022

ADAM metallopeptidase domain 12 overexpression correlates with prognosis and immune cell infiltration in clear cell renal cell carcinoma.

Junjie Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.